Stock Purchase Agreement between NeoTherapeutics, Inc. and Purchasers (July 8, 2002)

Contract Categories: Business Finance › Stock Agreements
Summary

This agreement, dated July 8, 2002, is between NeoTherapeutics, Inc. and several purchasers, including Alpha Capital A.G., Stonestreet L.P., Excalibur Limited Partnership, and Cranshire Capital L.P. The purchasers agree to buy, and NeoTherapeutics agrees to sell, specified shares of the company's common stock at $0.17 per share. The shares are registered, unrestricted, and will be delivered electronically after payment is wired to the company. The agreement outlines the purchase amounts and delivery instructions for both payment and shares.

Read More Arrow
EX-10.1 4 a82931exv10w1.htm EXHIBIT 10.1 exv10w1  

EXHIBIT 10.1

STOCK PURCHASE AGREEMENT

     This agreement is dated July 8, 2002 between ________ (“Purchaser”), and NeoTherapeutics, Inc. (“Company”), whereby the parties agree as follows:

     The Purchaser shall buy and the Company agrees to sell ________shares (“Shares”) of the Company’s Common Stock at a price of $0.17 per share for the total amount of ________. The Shares have been registered on a Form S-3, File No. 333-53108, which registration statement has been declared effective by the Securities and Exchange Commission. The Shares are free of restrictive legends and are free of any resale restrictions. The Company is delivering herewith a prospectus supplement on Form 424 (b)(2) regarding the sale of the Shares prior to funding.

     The Purchaser shall wire the purchase amount to the Company to the account set forth below.

Company Wire Transfer Instructions:

  Chase Manhattan Bank
1 Chase Plaza
New York, NY 10004
ABA # 021 000 021
FBO Salomon Smith Barney
A/C # 066-198038
For Further Credit to:
Neotherapeutics, Inc.
A/C # 561-04051-19-103

     The Company shall cause its transfer agent to transmit the Shares electronically to the Purchaser by crediting the account set forth below through the Deposit Withdrawal Agent Commission system.

     Purchaser DWAC Instructions:

 


-1-

 

  AGREED AND ACCEPTED:
     
  NeoTherapeutics, Inc.
 
 
  By: 
 
    Name:
Title:
     
  PURCHASER:
 
 
 
 
  By: 
 
    Name:
Title:

-2-

 

SCHEDULE 1

                 
Purchaser   Shares   Purchase Price
 
 
Alpha Capital A.G.
     2,941,177     $ 500,000  
Stonestreet L.P.
     1,764,705     $ 300,000  
Excalibur Limited Partnership
     882,353     $ 150,000  
Cranshire Capital L.P.
     882,353     $ 150,000  

-3-